[1]
|
Abbott, N.J. and Romero, I.A. (1996) Transporting therapeutics across the blood-brain barrier. Trends in Molecular Medicine, 2, 106-113.
http://dx.doi.org/10.1016/1357-4310(96)88720-X
|
[2]
|
Yang, F.Y., Lin, Y.S., Kang, K.H. and Chao, T.K. (2011) Reversible blood-brain barrier disruption by repeated transcranial focused ultrasound allows enhanced extravasation. Journal of Controlled Release, 150, 111-116.
http://dx.doi.org/10.1016/j.jconrel.2010.10.038
|
[3]
|
Yang, F.Y., Wang, H.E., Lin, G.L., Teng, M.C., Lin, H.H., Wong, T.T. and Liu, R.S. (2011) Micro-SPECT/ CT-based pharmacokinetic analysis of 99mTc-diethy- lenetriaminepentaacetic acid in rats with blood-brain barrier disruption induced by focused ultrasound. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 52, 478-484.
|
[4]
|
Yang, F.Y., Wong, T.T., Teng, M.C., Liu, R.S., Lu, M., Liang, H.F. and Wei, M.C. (2012) Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. Journal of Controlled Release, 160, 652-658.
http://dx.doi.org/10.1016/j.jconrel.2012.02.023
|
[5]
|
Hynynen, K., McDannold, N., Sheikov, N.A., Jolesz, F.A., Vykhodtseva, N. (2005) Local and reversible blood- brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage, 24, 12-20.
http://dx.doi.org/10.1016/j.neuroimage.2004.06.046
|
[6]
|
Yang, F.Y. and Lee, P.Y. (2012) Efficiency of drug delivery enhanced by acoustic pressure during blood-brain barrier disruption induced by focused ultrasound, International Journal of Nanomedicine, 7, 2573-2582.
http://dx.doi.org/10.2147/IJN.S31675
|
[7]
|
Hynynen, K. (2008) Ultrasound for drug and gene delivery to the brain. Advanced Drug Delivery Reviews, 60, 1209-1217. http://dx.doi.org/10.1016/j.addr.2008.03.010
|
[8]
|
Yang, F.Y., Wang, H.E., Lin, G.L., Lin, H.H. and Wong, T.T. (2012) Evaluation of the increase in permeability of the blood-brain barrier during tumor progression after pulsed focused ultrasound. International Journal of Nanomedicine, 7, 723-730.
http://dx.doi.org/10.2147/IJN.S28503
|
[9]
|
Yang, F.Y., Chen, C.C., Kao, Y.H., Chen, C.L., Ko, C.E., Horng, S.C. and Chen, R.C. (2013) Evaluation of dose distribution of molecular delivery after blood-brain barrier disruption by focused ultrasound with treatment planning. Ultrasound in Medicine & Biology, 39, 620-627.
http://dx.doi.org/10.1016/j.ultrasmedbio.2012.11.027
|
[10]
|
Kroll, R.A. and Neuwelt, E.A. (1998) Outwitting the blood-brain barrier for therapeutic purposes: Osmotic opening and other means. Neurosurgery, 42, 1083-1099; discussion, 1099-1100.
http://dx.doi.org/10.1097/00006123-199805000-00082
|
[11]
|
Pardridge, W.M. (2002) Drug and gene delivery to the brain: The vascular route. Neuron, 36, 555-558.
http://dx.doi.org/10.1016/S0896-6273(02)01054-1
|
[12]
|
McDannold, N., Vykhodtseva, N., Jolesz, F.A. and Hynynen, K. (2004) MRI investigation of the threshold for thermally induced blood-brain barrier disruption and brain tissue damage in the rabbit brain. Magnetic Resonance in Medicine: Official Journal of the Society of Magnetic Resonance in Medicine/Society of Magnetic Resonance in Medicine, 51, 913-923.
|